Home     지난뉴스레터보기
  발행인: 이종민   편집인: 이배영, 이지원, 김성목 News Letter Vol.31
 31TH Issue (November 2016)
Notice Atrium
   
S·P·O·N·S·O·R
GE

GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care.
Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.

Isosmolar Visipaque is PREPARED TO PROTECT:

Delivering diagnostic accuracy helping to minimize motion and stent artefacts.
Supporting CCTA patient care and comfort with a formulation designed for cardiac tolerability.
Reducing imaging associated complications facilitating dose optimization.

Putting diognostic accuracy and patient care at the heart of CCTA
Bayer


Bayer Radiology as the worldwide market leader in diagnostic imaging, we continue to drive forward innovation in CT & MRI. We are providing Ultravist® an well-balanced contrast medium for CT and X-ray, Gadovist® 1.0, only existing 1.0M MR contrast medium and Primovist®, a liver-specific MR contrast medium.
From 2012, Bayer Radiology continuously evolves portfolio: including contrast media, we expand our business with Radiation Dose Management System, RadimetricsTM Enterprise Platform and medical devices, Medrad® for your daily clinical work, but also for your research. Through this combination, Bayer Radiology hopes to offer you innovative solutions in radiology to improve medical procedures and patient care.






경기도 성남시 분당구 안골로 11번길 7, 202호
TEL : 031-704-4262  E-mail : kosci.heart@gmail.com
Copyright ⓒ by The Korean Society of Cardiovascular Imaging. All rights reserved.